Identity
- Security key
- 19145
- Ticker
- NGEN
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2019-03-25
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- NGEN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $187,286,234.08
- Shares outstanding (class)
- 80,630,871
- Shares outstanding (weighted)
- 106,412,633
- SIC
- —
- Employees
- 9
- Location
- —
- Homepage
- https://www.nervgen.com
- Description
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Market cap and share counts drift.